Atlas Trials

An Imaging Study of 64Cu-SARTATE Using Positron Emission Tomography in Patients With Neuroendocrine Tumours

Clinical trial NCT04440956 · COMPLETED

Trial details

NCT number
NCT04440956
Sponsor
Clarity Pharmaceuticals Ltd
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2015-05-21
Primary completion
2016-02-25
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.